Clinical Trial Update: Aralast NP in Islet Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for Aralast NP in islet transplantation for Type 1 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Aralast NP (alpha1-antitrypsin)

Snippet

Sponsor: University of Alberta | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED